| Outgoing Relation(s) |
| antilipemic drug (CHEBI:35679) is a drug (CHEBI:23888) |
| Incoming Relation(s) |
| (+)-schisandrin B (CHEBI:132471) has role antilipemic drug (CHEBI:35679) |
| (R)-carnitine (CHEBI:16347) has role antilipemic drug (CHEBI:35679) |
| trans-rhaponticin (CHEBI:8824) has role antilipemic drug (CHEBI:35679) |
| D-psicose (CHEBI:27605) has role antilipemic drug (CHEBI:35679) |
| 3-pyridinemethanol (CHEBI:45213) has role antilipemic drug (CHEBI:35679) |
| 4,5,4'-trihydroxy-3,3'-dimethoxybibenzyl (CHEBI:193138) has role antilipemic drug (CHEBI:35679) |
| akebia saponin D (CHEBI:194124) has role antilipemic drug (CHEBI:35679) |
| ascofuranone (CHEBI:156148) has role antilipemic drug (CHEBI:35679) |
| bempedoic acid (CHEBI:149601) has role antilipemic drug (CHEBI:35679) |
| berberine (CHEBI:16118) has role antilipemic drug (CHEBI:35679) |
| bezafibrate (CHEBI:47612) has role antilipemic drug (CHEBI:35679) |
| cerulenin (CHEBI:171741) has role antilipemic drug (CHEBI:35679) |
| ciprofibrate (CHEBI:50867) has role antilipemic drug (CHEBI:35679) |
| clofibrate (CHEBI:3750) has role antilipemic drug (CHEBI:35679) |
| clofibric acid (CHEBI:34648) has role antilipemic drug (CHEBI:35679) |
| compactin diol lactone (CHEBI:34652) has role antilipemic drug (CHEBI:35679) |
| diallyl trisulfide (CHEBI:78492) has role antilipemic drug (CHEBI:35679) |
| ethionamide (CHEBI:4885) has role antilipemic drug (CHEBI:35679) |
| ethionamide S-oxide (CHEBI:87805) has role antilipemic drug (CHEBI:35679) |
| ezetimibe (CHEBI:49040) has role antilipemic drug (CHEBI:35679) |
| fenofibrate (CHEBI:5001) has role antilipemic drug (CHEBI:35679) |
| fluvastatin sodium (CHEBI:5137) has role antilipemic drug (CHEBI:35679) |
| FR177391 (CHEBI:65911) has role antilipemic drug (CHEBI:35679) |
| fucoidan (CHEBI:5181) has role antilipemic drug (CHEBI:35679) |
| gemfibrozil (CHEBI:5296) has role antilipemic drug (CHEBI:35679) |
| herbacetin (CHEBI:27673) has role antilipemic drug (CHEBI:35679) |
| loteprednol (CHEBI:50848) has role antilipemic drug (CHEBI:35679) |
| marsupsin (CHEBI:66680) has role antilipemic drug (CHEBI:35679) |
| MEDICA 16 (CHEBI:149582) has role antilipemic drug (CHEBI:35679) |
| ML-236C (CHEBI:34828) has role antilipemic drug (CHEBI:35679) |
| monascin (CHEBI:82621) has role antilipemic drug (CHEBI:35679) |
| nafenopin (CHEBI:7449) has role antilipemic drug (CHEBI:35679) |
| naringenin 7-O-β-D-glucoside (CHEBI:28327) has role antilipemic drug (CHEBI:35679) |
| nicotinic acid (CHEBI:15940) has role antilipemic drug (CHEBI:35679) |
| pemafibrate (CHEBI:228365) has role antilipemic drug (CHEBI:35679) |
| perfluorooctane-1-sulfonic acid (CHEBI:39421) has role antilipemic drug (CHEBI:35679) |
| PF-06446846 (CHEBI:189659) has role antilipemic drug (CHEBI:35679) |
| probucol (CHEBI:8427) has role antilipemic drug (CHEBI:35679) |
| protodioscin (CHEBI:8588) has role antilipemic drug (CHEBI:35679) |
| rhapontigenin (CHEBI:174376) has role antilipemic drug (CHEBI:35679) |
| rosuvastatin (CHEBI:38545) has role antilipemic drug (CHEBI:35679) |
| salvigenin (CHEBI:192703) has role antilipemic drug (CHEBI:35679) |
| scoparone (CHEBI:9055) has role antilipemic drug (CHEBI:35679) |
| UAB126 (CHEBI:176496) has role antilipemic drug (CHEBI:35679) |
| xuezhikang (CHEBI:231891) has role antilipemic drug (CHEBI:35679) |
| anticholesteremic drug (CHEBI:35821) is a antilipemic drug (CHEBI:35679) |
